Thomas E. Seay

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.5K citations

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond et al. · Journal of Clinical Oncology · 2005 · 801 citations

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2010 · 593 citations

Oral Uracil and Tegafur Plus Leucovorin Compared With Intravenous Fluorouracil and Leucovorin in Stage II and III Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-06

Barry C. Lembersky, H. Samuel Wieand, Nicholas J. Petrelli et al. · Journal of Clinical Oncology · 2006 · 325 citations · Full text